ONKOS SURGICAL: Striking Innovation in Musculoskeletal Oncology
As a relatively newer subspecialty in orthopedics, musculoskeletal oncology features infinite potential for innovation and plethora of untapped opportunities. With a zeal to strike an innovation chord in this realm, Patrick Treacy, Antony Koblish and Adele Oliva, compiled years of their experience in the healthcare sector and founded ONKOS SURGICAL in 2015. “At ONKOS SURGICAL, we maintain a singular focus on musculoskeletal oncology and bring innovation to the market and responsiveness to the people suffering from cancer,” begins Treacy, CEO, and Co-Founder of ONKOS SURGICAL.
With a lifetime of expertise in surgical oncology, Patrick noticed the need to impart more focus and attention on musculoskeletal oncology and provide greater innovation for tumor patients and the surgeons who treat them. ONKOS SURGICAL is dedicated to addressing this challenge, by delivering high-quality implants, surgical instruments, and custom-made surgical solutions specifically designed for treating musculoskeletal tumor. While surgical technologies that enhance patient safety, facilitate surgical accuracy and lead to improved patient care are gaining steam in the realm of musculoskeletal oncology surgery, ONKOS SURGICAL is at the vanguard of this transformation. In an ambitious bid to bring innovation to musculoskeletal oncology surgeons, Onkos Surgical realized the profound impact they could make if they combined personalized 3D printed medical devices and instrumentation with patient-specific surgical simulation. “We leverage new technologies like 3D printing and imaging, to change the way cases are viewed, planned and optimized for individual patients,” adds Patrick.
ONKOS SURGICAL offers uDesign Patient Solutions, a cloud-based, consultative and concierge level service, which allows the surgeons to share specific information with ONKOS SURGICAL’S dedicated Concierge Engineering Team. uDesign upholds the level of expertise and surgical planning required in every medical case and renders solutions for almost all aspects of musculoskeletal oncology in real-time. While musculoskeletal tumours pose considerable challenges during resection and reconstruction, ELEOS Limb Salvage System from uDesign streamlines procedures where radical resection and replacement of distal femur, proximal femur, proximal tibia, or total femur is needed. ELEOS features operational simplicity combined with a proven design in a single comprehensive, interchangeable system. The ELEOS hinge knee design also facilitates a 50 valgus angle to assist restoration, thereby enhancing the stability, operative flexibility and patellofemoral kinematics of the user.
We leverage new technologies like 3D printing and imaging, to change the way cases are viewed, planned and optimized for individual patients
The advanced My3D Technology from ONKOS SURGICAL can be utilized to develop personalized implants, instruments, anatomic models and surgical procedure plans to assist surgeons in diverse tumor, fracture, and complex revision cases. High-quality image processors are used to segment CT scans and generate 3D computer models of the hard and soft (tumor) tissues in the body. These models can be further analyzed by the surgeons, with assistance from technical experts at ONKOS SURGICALS, to devise essential pre-operative and intra-operative surgical solutions, enabling them to better manage individual patient outcomes. The power to efficiently harness the benefits of 3D printing is what raises their stakes in the market.
uDesign holistically reckons regenerative biologics for patients with complications like wound closure, bone regeneration, and nerve or soft tissue disorders through their GenVie Regenerative Biologics Solutions. GenVie includes a range of biologic products— CYGNUS, VIA GRAFT and ALLOGRAFTS— with specific applications to assist in healing and regeneration.
While radically transforming surgical oncology, ONKOS SURGICAL is committed to raising awareness on sarcoma and pediatric cancer through fundraising activities, support for cancer research, and more. They are hoping to further extend their focus outside the orthopedic oncology space, in the revision and trauma markets. The company looks forward to harnessing the application of new technologies like Augmented Reality in musculoskeletal oncology through strategic partnerships, demonstrating leadership and setting up the agenda for innovation.
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: